Aytu BioScience Inc share price logo

Aytu BioScience Inc

NASDAQ: AYTU

Small Cap

$2.55

-0.02

(-0.78%)

Live

as on

Aytu BioScience Inc Stock Performance

as on May 7, 2026 at 12:33 am IST

  • $2.55
    $2.55
  • 52 Week's Low

    52 Week's High

    $1.20
    $3.07
    downward going graph

    52.94%

    Downside

    20.20%

    Upside

    downward going graph

Aytu BioScience Inc share price movements today

Previous Close
$2.57
Open
$2.55
Volume
108.0
Day's Low - High
$2.55 - $2.55
52 Week Low - High
$1.20 - $3.07

Aytu BioScience Inc Historical Returns

1 Month Return
-3.38 %
3 Month Return
+ 7.53 %
1 Year Return
+ 105.6 %
3 Year Return
+ 67.97 %
5 Year Return
-97.81 %

Aytu BioScience Inc Stock Fundamentals & Key Indicators

Check Aytu BioScience Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$27.4M

EPS (TTM)

-1.24

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

4.0M

Revenue (TTM)

62.6M

Profit Margin

-39.02%

Return On Equity TTM

-109.23%

Aytu BioScience Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Aytu BioScience Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$27.4M-97.81%NA-39.02%
BUY$24.3BNA20.5441.94%
HOLD$17.7B11.41%NA-24.58%
BUY$40.7BNA18.3415.11%
BUY$47.5B-32.82%18.6928.24%

Stock Returns calculator for Aytu BioScience Inc Stock including INR - Dollar returns

The Aytu BioScience Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Aytu BioScience Inc investment value today

Current value as on today

₹2,28,936

Returns

₹1,28,936

(+128.94%)

Returns from Aytu BioScience Inc Stock

₹1,04,000 (+104%)

Dollar Impact

₹24,936 (+24.94%)

Analyst Recommendation on Aytu BioScience Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Aytu BioScience Inc. Average target price of $9.33

Aytu BioScience Inc Share Price Target

Get share price movements and forecasts by analysts on Aytu BioScience Inc.

What analysts predicted

72.67%UPSIDE

Target Price

$9.33

Current Price

$2.55

Analyzed by

7 Analysts

Target

$9.33

Aytu BioScience Inc target price $9.33, a slight upside of 72.67% compared to current price of $2.55. According to 7 analysts rating.

Indian Investors' Interest in Aytu BioScience Inc Stock

Search interest for Aytu BioScience Inc Stock has decreased by -78% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-78% versus previous 30 day period

Aytu BioScience Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
17
18
14
17
16
16
18
15
13
15
Gross Profit
13
14
10
11
11
10
12
10
9
9
Operating Income
0
3
-1
-3
0
-1
2
-7
-1
-1
EBITDA
-4
4
1
-5
3
2
6
-17
3
-9
Interest Expense
1
1
1
4
0
1
0
0
0
0
Depreciation
2
2
1
1
1
1
1
1
0
0
Income Before Tax
-7
1
-1
-3
1
0
3
-19
1
-10
Income Tax Expense
-2
0
0
0
0
0
0
0
-
-
Net Income
-8
0
-2
-4
1
0
3
-19
1
-10
Net Profit Margin
-45.57%
-1.17%
-20.58%
-25.68%
8.89%
4.86%
21.65%
-130.94%
14.15%
-69.79%

Aytu BioScience Inc Annual Profit & Loss

All numbers in Millions USD

Jun 2016
Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Total Revenue
2
3
3
7
27
65
96
107
65
66
Gross Profit
1
1
1
5
19
29
50
66
49
45
Operating Income
-21
-20
-19
-16
-21
-58
-109
-17
-1
-7
EBITDA
-21
-18
-15
-14
-12
-29
-27
-3
1
-4
Interest Expense
5
2
0
-
-
37
147
4
4
3
Depreciation
-
4
2
2
6
9
10
4
8
5
Income Before Tax
-28
-22
-10
-27
-13
-58
-108
-17
-10
-13
Income Tax Expense
8
1
-2
20
-9
0
0
0
2
0
Net Income
-28
-22
-10
-47
-13
-58
-108
-17
-15
-13
Net Profit Margin
-1099.73%
-698.67%
-278.36%
-644.33%
-49.29%
-88.81%
-112.53%
-15.88%
-24.31%
-20.43%

Aytu BioScience Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
0
-2
-4
1
0
3
-19
1
-10
Operating Cash Flow
0
0
0
-1
2
-6
2
0
3
Investing Cash Flow
0
0
0
0
0
0
-3
-
0
Financing Cash Flow
0
0
1
0
-2
4
12
2
-6
Change in Cash
0
0
0
0
0
-2
12
1
-2

Aytu BioScience Inc Annual Cash Flow

All numbers in Millions USD

Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Net Income
-22
-10
-27
-13
-58
-108
-17
-15
-13
Operating Cash Flow
-13
-15
-13
-28
-25
-28
-5
-1
-1
Investing Cash Flow
-3
0
-1
-5
-2
-3
0
0
-2
Financing Cash Flow
10
22
19
71
30
1
8
-1
15
Change in Cash
-7
6
4
37
1
-30
3
-2
10

Global Institutional Holdings in Aytu BioScience Inc

Funds
Holdings
Daytona Street Capital LLC
0.09%
Geode Capital Management, LLC
0.66%
Awm Investment Company Inc
5.77%
Two Sigma Investments LLC
1%
DRW Securities, LLC
0.27%

Insights on Aytu BioScience Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, AYTU has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, AYTU stock has moved up by 105.6%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 13.88M → 15.16M (in $), with an average increase of 8.4% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation has given 167.2% return, outperforming this stock by 99.2%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 1.96M → -10.58M (in $), with an average decrease of 638.6% per quarter

About Aytu BioScience Inc

Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT extended-release orally disintegrating tablets for patients from six years of age and above; Cotempla XR-ODT extended-release orally disintegrating tablets for patients from six to seventeen years old; and Metadate CD, a central nervous system stimulant indicated for the treatment of ADHD. It also provides pediatric prescription product portfolio comprising Karbinal ER, an extended-release carbinoxamine (antihistamine) suspension indicated to treat numerous allergic conditions for patients two years and above; and Poly-Vi-Flor and Tri-Vi-Flor complementary prescription fluoride-based multi-vitamin products containing combinations of fluoride and vitamins in liquid and chewable tablet form for infants and children with fluoride deficiency. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu BioPharma, Inc. in March 2021. Aytu BioPharma, Inc. is headquartered in Denver, Colorado.
OrganisationAytu BioScience Inc
HeadquartersDenver Corporate Center III, Denver, CO, United States, 80237
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. Joshua R. Disbrow
E-voting on sharesClick here to vote

Key Management of Aytu BioScience Inc

Name

Title

Dr. Gerwin Westfield Ph.D.

Senior Vice President of Scientific Affairs

Mr. Joshua R. Disbrow

CEO & Director

Mr. Ryan J. Selhorn CPA

CFO, Corporate Secretary & Treasurer

Mr. Jarrett T. Disbrow Ph.D.

Chief Business Officer

Mr. Greg Pyszczymuka

Chief Commercial Officer

Ms. Margaret Cabano

Vice President of Operations

FAQs

What is Aytu BioScience Inc share price today?

Aytu BioScience Inc share price today is $2.55 as on . Aytu BioScience Inc share today touched a day high of $2.55 and a low of $2.55.

What is the 52 week high and 52 week low for Aytu BioScience Inc share?

Aytu BioScience Inc share touched a 52 week high of $3.07 on and a 52 week low of $1.2 on . Aytu BioScience Inc stock price today i.e. is trending at $2.55,which is 16.80% down from its 52 week high and 112.50% up from its 52 week low.

What is Aytu BioScience Inc's market capitalisation today?

Aytu BioScience Inc market capitalisation is $0.00T as on .

How to invest in Aytu BioScience Inc Stock (AYTU) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Aytu BioScience Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Aytu BioScience Inc Shares that will get you 0.5882 shares as per Aytu BioScience Inc share price of $2.55 per share as on May 6, 2026 at 7:03 pm IST.

What is the minimum amount required to buy Aytu BioScience Inc Stock (AYTU) from India?

Indian investors can start investing in Aytu BioScience Inc (AYTU) shares with as little as ₹94.61 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.10 in Aytu BioScience Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Aytu BioScience Inc share’s latest price of $2.55 as on May 6, 2026 at 7:03 pm IST, you will get 3.9216 shares of Aytu BioScience Inc. Learn more about fractional shares .

What are the returns that Aytu BioScience Inc has given to Indian investors in the last 5 years?

Aytu BioScience Inc stock has given -97.81% share price returns and 29.19% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?